Serber Zachariah

Chief Science Officer, DirectorZymergen Inc. (ZY) · full profile →Form 4 · filed Apr 22, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2021Disposed to issuer(D)67K$29.67$2.0M2.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 21, 2021Grant(A)458K$0458K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-013980) within minutes of acceptance. Every field above traces to the original document. Verify it directly: